Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€70.12
21.02.21
€85.00
-1.80%
22.03.21

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€22.09
21.02.21
€25.00
20.33%
22.03.21

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€8.98
21.02.21
€10.00
21.02.22
-54.90%
22.02.22

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.68
21.02.21
€113.00
21.02.22
-1.60%
22.02.22

buy
Inovio Pharma

Start price
Target price
Perf. (%)
€11.30
20.02.21
€6.80
20.02.22
-38.75%
10.07.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
iBio Inc.

Start price
Target price
Perf. (%)
€41.75
20.02.21
€27.50
20.02.22
-19.76%
06.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€23.36
20.02.21
€26.40
20.02.22
-34.73%
06.05.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Evolus Inc

Start price
Target price
Perf. (%)
€10.32
20.02.21
€5.00
-6.45%
06.03.21

Novan Inc

Start price
Target price
Perf. (%)
€14.70
19.02.21
-
19.02.22
-50.68%
22.07.21

buy
Hexo Corp.

Start price
Target price
Perf. (%)
€93.80
19.02.21
€210.00
19.02.22
-66.72%
23.08.21

Could be worthwhile Investment >10% per year
Cytocom Inc.

Start price
Target price
Perf. (%)
€9.20
18.02.21
-
18.02.22
-68.91%
29.08.21

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€8.24
18.02.21
€15.00
18.02.22
-31.31%
19.10.21

Novan Inc

Start price
Target price
Perf. (%)
€16.80
18.02.21
€30.00
17.08.21
-57.98%
17.08.21

Could be very worthwhile Investment >20% year
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€1.79
17.02.21
-
17.02.22
29.05%
08.12.21

Amgen Inc.

Start price
Target price
Perf. (%)
€195.08
17.02.21
-
17.02.22
0.69%
18.02.22

Senseonics Holdings Inc

Start price
Target price
Perf. (%)
€4.61
17.02.21
-
17.02.22
-34.98%
28.10.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€141.75
17.02.21
€150.00
1.98%
23.03.21

Nanorepro AG

Start price
Target price
Perf. (%)
€8.95
16.02.21
€5.00
16.02.22
-7.49%
18.10.21

Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€49.41
16.02.21
-
21.43%
21.02.21

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€2.17
16.02.21
-
-7.37%
22.03.21

buy
Novan Inc

Start price
Target price
Perf. (%)
€20.00
16.02.21
€30.00
17.08.21
-16.00%
18.02.21

Could be very worthwhile Investment >20% year
buy
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€24.48
15.02.21
-
15.02.22
-59.86%
06.09.21

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€25.99
15.02.21
-
15.02.22
-6.14%
23.06.21

buy
Perrigo Co. plc

Start price
Target price
Perf. (%)
€37.00
15.02.21
-
15.02.22
5.95%
11.07.21

Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€15.40
15.02.21
€19.00
15.02.22
-14.92%
15.02.22

Undervalued
High dividend yield expected